Shop

Description

TRADEMARK & DISTRIBUTION NOTICE: Independent distributor. Not affiliated with Galderma.

Precision Engineering: The NASHA Technology Advantage

Restylane Lidocaine remains a cornerstone of aesthetic medicine in 2026. Its global reputation is built on the patented NASHA (Non-Animal Stabilized Hyaluronic Acid) technology. Unlike many modern fillers that use a smooth, ‘monophasic’ gel, Restylane is ‘biphasic’, meaning it consists of precisely calibrated gel particles. This allows the practitioner to achieve a high degree of precision; the gel stays exactly where it is placed, resisting migration even in high-movement areas of the face. It is specifically designed for the correction of moderate facial wrinkles, such as nasolabial folds, marionette lines, and for enhancing the vermillion border of the lips.

Clinical Performance and Patient Comfort

What sets Restylane apart is its high G-prime (elastic modulus). This provides a robust mechanical lift, allowing for the restoration of facial volume with less product. The integrated 0.3% lidocaine ensures that the patient experience is significantly improved, reducing pain during and after the injection. When injected into the mid-to-deep dermis, Restylane provides a stable scaffold that not only fills wrinkles but supports the skin’s architecture. Results are predictably natural and can last up to 12 months, making it one of the most reliable investments for any professional clinic focused on patient satisfaction and safety.

Protocol and Safety Standards

Restylane Lidocaine is a Class III medical device and should only be administered by trained professionals using sterile techniques. It is supplied in a 1ml pre-filled syringe with thin-wall needles to facilitate smooth extrusion. Its safety profile is supported by over two decades of clinical data, ensuring minimal inflammatory response and excellent tissue integration.